Lantern Pharma Inc.
LTRN · NASDAQ
Bulios Fair Price
$1.22
50.1% upside
Trenutna cena
$0.81
Po podatkih Bulios Fair Price je delnica LTRN trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Lantern Pharma Inc. is a biotechnology company focused on developing personalized therapeutic approaches for cancer patients. The company utilizes advanced bioinformatics and artificial intelligence to identify genetic and molecular characteristics of cancer tumors, enabling better targeting of therapeutic strategies for individual patients. Lantern Pharma focuses on discovering and developing new drugs and combination therapies that could be effective in patients with various types of cancer, including those who have not been successfully treated by standard methods. The goal of Lantern Pharma is to bring innovative treatment approaches and improve treatment outcomes for cancer patients.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Panna Sharma
Employees
16
Headquarters
Dallas
Prihajajoči dogodki
Earnings
Upcoming earnings report